All Stories

  1. PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Rakesh Kukreja

  2. Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity

    Article • Molecular Pharmacology, June 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Rakesh Kukreja

  3. Sildenafil and Cardioprotection

    Article • Current Pharmaceutical Design, November 2013, Bentham Science Publishers

    Rakesh Kukreja

  4. Preconditioning by Phosphodiesterase‐5 Inhibition Improves Therapeutic Efficacy of Adipose‐Derived Stem Cells Following Myocardial Infarction in Mice

    Article • Stem Cells, January 2012, Oxford University Press (OUP)

    Rakesh Kukreja